Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
35
TAK Quote, Financials, Valuation and Earnings
Last price:
$15.02
Seasonality move
:
1.88%
Day range:
$14.88 - $15.04
52-week range:
$12.58 - $15.43
Dividend yield:
4.11%
P/E ratio:
68.88x
P/S ratio:
1.61x
P/B ratio:
1.01x
Volume:
1.7M
Avg. volume:
2.1M
1-year change:
15.35%
Market cap:
$46.9B
Revenue:
$30.1B
EPS (TTM):
$0.22
Earnings Data
Next earnings date for TAK
Oct 31
2025
Most recent earnings per share
-$0.21
Missed by $0.21
(May 8/2025)
Consensus Estimate
--
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TAK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $8B | -- | -- | -- | -- |
| 05/08/2025 | Q1 | $7.6B | $6.9B | -$0.21 | -- | -- |
| 01/30/2025 | Q4 | $7.3B | $7.5B | $0.05 | -- | -- |
| 10/31/2024 | Q3 | $7.2B | $7.9B | $0.19 | -- | -- |
| 07/31/2024 | Q2 | $6.8B | $7.7B | $0.19 | -- | -- |
| 05/09/2024 | Q1 | $5.8B | $7.1B | -$0.01 | -- | -- |
| 02/01/2024 | Q4 | $6.8B | $7.5B | $0.23 | -- | -- |
| 10/26/2023 | Q3 | -- | -- | -$0.11 | -- | -- |
| 07/27/2023 | Q2 | -- | -- | $0.21 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | $0.07 | -- | -- |
| 02/02/2023 | Q4 | -- | -- | $0.27 | -- | -- |
| 10/27/2022 | Q3 | -- | -- | $0.14 | -- | -- |
| 07/28/2022 | Q2 | -- | -- | $0.26 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.03 | -- | -- |
| 02/03/2022 | Q4 | -- | -- | $0.16 | -- | -- |
| 10/28/2021 | Q3 | -- | -- | $0.13 | -- | -- |
| 07/30/2021 | Q2 | -- | -- | $0.40 | -- | -- |
| 05/11/2021 | Q1 | -- | -- | $0.59 | -- | -- |
| 02/04/2021 | Q4 | -- | -- | $0.28 | -- | -- |
| 10/29/2020 | Q3 | -- | -- | $0.01 | -- | -- |
| 07/31/2020 | Q2 | -- | -- | $0.24 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.10 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | $0.16 | -- | -- |
Takeda Pharmaceutical Earnings Questions
-
How Much did Takeda Pharmaceutical Generate in Revenue Last Quarter?
Takeda Pharmaceutical reported $6.9B worth of top line sales in its most recent quarter.
-
Did Takeda Pharmaceutical Beat Earnings Last Quarter?
Takeda Pharmaceutical announced earnings per share of -$0.21 which represents a miss of analyst forecast a -- per share.
-
Is Takeda Pharmaceutical Profitable?
Takeda Pharmaceutical reported $4.4B that represents $1.35 per share over the last quarter.
-
What is the Analyst Consensus for Takeda Pharmaceutical EPS Next Year?
Takeda Pharmaceutical's earnings are forecast to grow from $0.22 per share to -- per share next year representing an increase of --.
-
When is Takeda Pharmaceutical's Earnings Date?
Takeda Pharmaceutical's next earnings date is October 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
